Myrbetriq - 0469-2601-30 - (mirabegron)

Alphabetical Index


Drug Information of Myrbetriq

Product NDC: 0469-2601
Proprietary Name: Myrbetriq
Non Proprietary Name: mirabegron
Active Ingredient(s): 25    mg/1 & nbsp;   mirabegron
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Myrbetriq

Product NDC: 0469-2601
Labeler Name: Astellas Pharma US, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202611
Marketing Category: NDA
Start Marketing Date: 20120628

Package Information of Myrbetriq

Package NDC: 0469-2601-30
Package Description: 1 BOTTLE in 1 CARTON (0469-2601-30) > 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE

NDC Information of Myrbetriq

NDC Code 0469-2601-30
Proprietary Name Myrbetriq
Package Description 1 BOTTLE in 1 CARTON (0469-2601-30) > 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Product NDC 0469-2601
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name mirabegron
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20120628
Marketing Category Name NDA
Labeler Name Astellas Pharma US, Inc.
Substance Name MIRABEGRON
Strength Number 25
Strength Unit mg/1
Pharmaceutical Classes beta3-Adrenergic Agonist [EPC],Adrenergic beta3-Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA]

Complete Information of Myrbetriq


General Information